Kiran Nistala - Jun 18, 2024 Form 4 Insider Report for Zura Bio Ltd (ZURA)

Role
Chief Medical Officer and Head of Development
Signature
/s/ Kiran Nistala
Stock symbol
ZURA
Transactions as of
Jun 18, 2024
Transactions value $
$0
Form type
4
Date filed
6/21/2024, 06:10 PM
Previous filing
Sep 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZURA Employee Share Option (Right to Buy) Award $0 +285K $0.00 285K Jun 18, 2024 Class A Ordinary Shares 285K $3.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth (1/4th) of the shares subject to the option award shall vest on June 18, 2025, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Remarks:

Chief Medical Officer and Head of Development